Happy #NationalInternDay! Thank you, Life Science Cares Boston, for bringing us such brilliant summer interns through Project Onramp! Our interns have already contributed so much to our team, and we are excited to watch them shape the future of #lifesciences. We are thrilled to celebrate you today with a special treat.
Nimbus Therapeutics
Biotechnology Research
Cambridge, Massachusetts 14,880 followers
Applying deep computational chemistry expertise to create novel small molecule therapeutics.
About us
At Nimbus, we design breakthrough medicines. Utilizing our powerful structure-based drug discovery engine, we create potent and selective small molecule compounds targeting proteins that are known to be fundamental drivers of pathology in highly prevalent human diseases and which have proven difficult for other drug makers to tackle. With a decade-plus track record of success, we’ve built a world-class team in both computationally driven drug discovery and early clinical development while continuing to move the needle for patients.
- Website
-
http://www.nimbustx.com/
External link for Nimbus Therapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Privately Held
- Specialties
- computational chemistry, biochemistry, small molecule therapeutics, oncology, immunology, metabolism, and drug development
Locations
-
Primary
130 Prospect St
Ste 301
Cambridge, Massachusetts 02139, US
Employees at Nimbus Therapeutics
Updates
-
Our research partners at Anagenex published an article in Biopharma Dealmakers, a Springer Nature Group publication, highlighting how they're combining ultra-throughput biochemistry and #machinelearning to address some of the hardest targets in drug discovery. We are proud to collaborate with Anagenex to discover precision small molecule therapeutics for multiple indications. Read the full article here: https://lnkd.in/eCa8dsFZ
-
Many thanks to Biotech2050 and co-host Rahul Chaturvedi for a thoughtful and wide-ranging discussion with our CEO Jeb Keiper around his career, leadership role, and Nimbus’ unique business model for #drugdiscovery and development.
Check out our latest episode of Biotech 2050! Host Rahul Chaturvedi sits down with Jeb Keiper, CEO of Nimbus Therapeutics. 🌟 In this episode, Jeb shares his incredible journey from a chemist at MIT to leading Nimbus Therapeutics for nearly a decade, providing insights into the unique operating and financing strategies that have driven Nimbus's success. Key Takeaways: 🔹 Evolution of biotech financing and strategic approaches 🔹 The importance of taking bold risks and innovative thinking 🔹 Insights into managing a biotech company through challenging capital markets 🔹 Building a resilient and collaborative team Tune in for valuable insights and the future of biotech! 🎙️✨ 🎧 Listen now: https://lnkd.in/ek7VjqB6 #Biotech2050 #BiotechInnovation #DrugDevelopment #FutureOfBiotech #BiotechPodcast #BiotechEcosystem #ScienceAndBusiness
-
Today we’re celebrating #French and #Belgian National Days with our multinational colleagues, immersing ourselves in the rich culture and history of their native countries. We are thrilled to observe these holidays with our teammates, including Daria Chabas, our Clinical Trial Manager with deep ties to France.
-
-
We are so proud of Christine Loh, SVP, Biology at Nimbus, who has been chosen to be a member of the 2024 Women In Bio Boardroom Ready Cohort! The program is designed to fuel women’s participation on corporate boards and has helped launch more than 150 corporate board appointments since the program’s inception. We look forward to supporting Christine as she extends her leadership in life science board rooms!
We are proud to present our 2024 Boardroom Ready Cohort! The Boardroom Ready Program was created in 2016 to assist executive women in the life sciences secure their first director role, and to date the program has 200 alumnae who make a lasting and positive impact on corporate boards. Join us in congratulating the 25 women that make up this outstanding 2024 Boardroom Ready Cohort 👏 Learn more about the program and this cohort on our website: https://lnkd.in/gVc6sFtM Allison Gaw | Barbara McClung | Barbara Wood | Beth Clarke | Bethany Dudek | Charlotte Arnold | Christine Loh | Eleni Lagos | Heather Arnett | Hong I. Wan | Janneke Meulenberg | Jen Beachell | Jennifer Leonard | Jessica Baker Flechtner | Katarina Luptakova | Kitty Yale | Laura Richman, MBA, PhD, DVM, DACVP | Lauren D'Angelo, MBA | Lauren White | Leslie Meltzer | Pallavi Garg | Rachel B. Wagman, M.D. | Shelby Walker | Sonali Fonseca, PhD | Valerie D'Souza Jaiswal
-
-
As we continue to welcome our summer interns from Project Onramp, a program of Life Science Cares Boston, we are grateful to our many partners who have generously provided their support and resources to make this initiative a success. We appreciate the invaluable contributions of these partners in empowering the next generation of scientists and innovators. • ChemDraw is a software product from Revvity Signals that offers powerful tools for drawing chemical structures and reactions, widely used in chemical research and education. • SciFinder is a research discovery application that provides access to a comprehensive and authoritative source of references, substances, and reactions in chemistry and related fields, developed by CAS. • LiveDesign is a collaborative drug design platform from Schrödinger that integrates data and computational models to enhance the drug discovery process. • Conga provides digital transformation solutions, including document generation, contract lifecycle management, and process automation, to streamline business operations and improve efficiency.
-
-
For our latest #Nimbi Giving Back Day, our team partnered with two incredible LGBTQ+ organizations in honor of #PrideMonth. Together we created self-care, hygiene, and welcome kits to support Friendship Works, an organization that helps to decrease LGBTQ+ elder isolation, and Waltham House, part of The Home for Little Wanderers that assists LGBTQ+ teens with a safe place to live.
-
-
On the “Healthscape” podcast from Northwestern University - Kellogg School of Management, our Chief Business Officer Abbas Kazimi talks about what drives authentic communication. “I’ve had a family history of cancer. This is why I want to challenge myself. And that authenticity opens the door for my colleagues to share their own personal experiences with illnesses… why they work in our industry… why they are so passionate.” Find the episode here: https://lnkd.in/dru-7-_9
-
-
We took our summer interns from Project Onramp out to the ballgame! Many thanks to Life Science Cares Boston for creating wonderful opportunities for these talented young individuals who represent the future of #lifesciences.
-
-
Our Director of Computational Chemistry, Leela Sriram Dodda, Ph.D., is in Seattle this week for the 38th National Medicinal Chemistry Symposium organized by the ACS Division of Medicinal Chemistry. It’s a great opportunity to highlight how we are using physics-based #MachineLearning methods to accelerate the design of novel chemical matters with computation. #NMCS2024 #MedicinalChemistry
Join us in Seattle, WA, US on June 23-26, 2024, for the 38th National Medicinal Chemistry Symposium organized by the ACS Division of Medicinal Chemistry. Follow our cutting-edge program chaired by Rheem Totah and Patrick Burke. Early-bird registration deadline is February 14, while poster abstracts can be submitted until March 14 ⌛ ✅ Visit www.nmcsmedi.org for details. Don't miss out! #NMCS2024 #MedicinalChemistry
-